Supernus Pharmaceuticals | Resultado Líquido



Net Income Alterar Data
Abbott USD 1.78B 454M 2025-06
ANI Pharmaceuticals USD 15.68M 25.96M 2025-03
Aurora Cannabis CAD 31.67M 43.71M 2024-12
Bristol-Myers Squibb USD 1.31B 1.15B 2025-06
Canopy Growth CAD -121896000 6.4M 2024-12
Corcept Therapeutics USD 35.15M 14.6M 2025-06
Eisai JPY 949M 22.84B 2025-03
Eli Lilly USD 2.76B 1.65B 2025-03
Novo Nordisk 29.03B 1.73B 2025-03
Pacira USD 4.81M 11.23M 2025-03
Perrigo USD -6400000 38.1M 2025-03
Pfizer USD 2.97B 2.56B 2025-03
Supernus Pharmaceuticals USD 15.33M 23.17M 2024-12
United Therapeutics USD 309.5M 12.7M 2025-06
Xeris Pharmaceuticals USD -54836000 39.1M 2024-12


Supernus Pharmaceuticals Resultado Líquido - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.